These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 20675197

  • 1. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies.
    Orange JS, Grossman WJ, Navickis RJ, Wilkes MM.
    Clin Immunol; 2010 Oct; 137(1):21-30. PubMed ID: 20675197
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia.
    Aghamohammadi A, Moin M, Farhoudi A, Rezaei N, Pourpak Z, Movahedi M, Gharagozlou M, Nabavi M, Shahrokhi A.
    FEMS Immunol Med Microbiol; 2004 Mar 08; 40(2):113-8. PubMed ID: 14987729
    [Abstract] [Full Text] [Related]

  • 3. Pneumococcal antibody levels in children with PID receiving immunoglobulin.
    Tuerlinckx D, Florkin B, Ferster A, De Schutter I, Chantrain C, Haerynck F, Philippet P, Strengers P, Laub R.
    Pediatrics; 2014 Jan 08; 133(1):e154-62. PubMed ID: 24366995
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.
    Jolles S, Bernatowska E, de Gracia J, Borte M, Cristea V, Peter HH, Belohradsky BH, Wahn V, Neufang-Hüber J, Zenker O, Grimbacher B.
    Clin Immunol; 2011 Oct 08; 141(1):90-102. PubMed ID: 21705277
    [Abstract] [Full Text] [Related]

  • 5. Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children.
    Suri D, Bhattad S, Sharma A, Gupta A, Rawat A, Sehgal S, Singh S, Gupta S.
    J Clin Immunol; 2017 Apr 08; 37(3):311-318. PubMed ID: 28321612
    [Abstract] [Full Text] [Related]

  • 6. Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levels.
    Cottler-Fox M, Lynch M, Pickle LW, Cahill R, Spitzer TR, Deeg HJ.
    Bone Marrow Transplant; 1991 Jul 08; 8(1):27-33. PubMed ID: 1655138
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics.
    Shapiro RS.
    Pediatr Allergy Immunol; 2013 Feb 08; 24(1):49-53. PubMed ID: 23331529
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies.
    Berger M, Rojavin M, Kiessling P, Zenker O.
    Clin Immunol; 2011 May 08; 139(2):133-41. PubMed ID: 21353644
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The efficacy of immunoglobulin replacement therapy in the long-term follow-up of the B-cell deficiencies (XLA, HIM, CVID).
    Bayrakci B, Ersoy F, Sanal O, Kiliç S, Metin A, Tezcan I.
    Turk J Pediatr; 2005 May 08; 47(3):239-46. PubMed ID: 16250308
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency.
    Pourpak Z, Aghamohammadi A, Sedighipour L, Farhoudi A, Movahedi M, Gharagozlou M, Chavoshzadeh Z, Jadid L, Rezaei N, Moin M.
    J Microbiol Immunol Infect; 2006 Apr 08; 39(2):114-20. PubMed ID: 16604243
    [Abstract] [Full Text] [Related]

  • 14. Post-marketing observational study on 5% intravenous immunoglobulin therapy in patients with secondary immunodeficiency and recurrent serious bacterial infections.
    Günther G, Dreger B.
    Microbiol Immunol; 2013 Jul 08; 57(7):527-35. PubMed ID: 23607863
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical and laboratory characteristics of 75 patients with specific polysaccharide antibody deficiency syndrome.
    Cheng YK, Decker PA, O'Byrne MM, Weiler CR.
    Ann Allergy Asthma Immunol; 2006 Sep 08; 97(3):306-11. PubMed ID: 17042135
    [Abstract] [Full Text] [Related]

  • 18. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.
    Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME.
    Medicine (Baltimore); 2003 Nov 08; 82(6):373-84. PubMed ID: 14663287
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of Site of Care on Infection Rates Among Patients with Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin Therapy.
    Wasserman RL, Ito D, Xiong Y, Ye X, Bonnet P, Li-McLeod J.
    J Clin Immunol; 2017 Feb 08; 37(2):180-186. PubMed ID: 28160239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.